Table 1. Digenic inheritance of the ALDH2 rs671 defective allele and ADH5 biallelic mutations identified in AMeDS individuals.
Family
ID |
Individual
ID |
Sex |
Initial
diagnosis* |
ADH5 mutations | ALDH2 mutations |
Hematological
abnormalities** |
Other
complications*** |
Remarks**** | ||
Allele1 | Allele2 | Allele1 | Allele2 | |||||||
1 | N0608 | F | FA | p.W322* | p.W322* | p.E504K | WT | NA | NA | UPD (ADH5 locus) |
2 | N0611 | F | AA |
Splicing
c.564+1G>A |
p.A278P | p.E504K | WT | NA | NA | |
Father2 | Normal | c.564+1G>A | WT | p.E504K | WT | |||||
Sibling2-1 | F | Normal | WT | WT | WT | WT | ||||
3 | N0614 | M | AA | p.W322* | p.A278P | p.E504K | WT | NA | NA | |
4 | N1037 | F | BS | p.W322* | p.W322* | p.E504K | p.E504K | MDS (2) |
SS (n.d.), MC, MD,
NR, TC, HP, ID |
Died from
interstitial pneumonia (9 years) |
N1254 | F | RA | p.W322* | p.W322* | p.E504K | p.E504K | AML (2) |
SS (−5.2), MC,
MD, NR, TC |
Died after BMT (3
years) |
|
Father4 | Normal | p.W322* | WT | p.E504K | p.E504K | |||||
Mother4 | Normal | p.W322* | WT | p.E504K | WT | |||||
Sibling4-1 | F | Normal | p.W322* | WT | p.E504K | p.E504K | ||||
5 | N1267 | F | DS | p.W322k | p.A278P | p.E504K | WT | MDS (7) |
SS (−5.4), MC,
MG, PLSVC, ID |
Alive after second
BMT (14 years) |
Sibling5-1 | M | Normal | WT | WT | p.E504K | WT | ||||
6 | N1269 | F | FA | p.W322* | p.W322* | p.E504K | WT | MDS (3) |
SS (−4.0), MD,
ASD, ADHD, ID |
Alive after BMT
(8 years) |
N1270 | M | FA | p.W322* | p.W322* | p.E504K | p.E504K | MDS (0) |
SS (−4.7), MC
(−5.8), MD, TC, AH, GA, HP, ID |
Died from an
infection (2 years) |
|
Father6 | Normal | p.W322* | WT | p.E504K | WT | |||||
Mother6 | Normal | p.W322* | WT | p.E504K | WT | |||||
Sibling6-1 | F | Normal | WT | WT | p.E504K | WT | ||||
Sibling6-2 | F | Normal | p.W322* | WT | p.E504K | WT | ||||
7 | N1275 | F | FA | p.W322* | p.A278P | p.E504K | WT | MDS (8) |
MC, SS (−4.1), HP,
UH, DC, HD, LD, ID |
Alive after BMT
(12 years) |
Father7 | Normal | p.W322* | WT | WT | WT | |||||
Mother7 | Normal | p.A278P | WT | p.E504K | WT | |||||
Sibling7-1 | F | Normal | WT | WT | WT | WT | ||||
8 | N1329 | M | FA | p.W322* | p.A278P | p.E504K | WT | MDS (12) |
MC, SS (−3.2),
HP, ID, PP |
Alive (16 years) |
Father8 | Normal | p.W322* | WT | p.E504K | p.E504K | |||||
Sibling8-1 | Normal | WT | WT | p.E504K | WT | |||||
9 | NAG16714 | F | Normal | p.S75N | p.S75N | WT | WT |
No previous
disease (55 years) |
Affected individuals and Nagahama case are shown in bold.
*FA, Fanconi anemia; AA, aplastic anemia; RA, refractory anemia; BS, Bloom syndrome; DS, Dubowitz syndrome.
**Ages at onset are in parentheses. MDS, myelodysplastic syndromes; AML, acute myeloid leukemia. NA, not analyzed.
***SD in parentheses. n.d., not determined; SS, short stature; MC, microcephaly; MD, motor deterioration; NR, nasal ridge; TC, telecanthus; HP, hyperpigmentation; ID, intellectual disability; MG, micrognathia; PLSVC, persistent left superior vena cava; ASD, autistic spectrum disorder; ADHD, attention-deficit hyperactivity disorder; AH, adrenal hypoplasia; GA, gonadal abnormality; UH, uterus hypoplasia; DC, dolichocephaly; HD, hyperdactyly (long thumb); LD, learning disability; PP, Precocious puberty.
****UPD, uniparental isodisomy; BMT, bone marrow transplant.